Filing Details
- Accession Number:
- 0001708138-21-000050
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-10 17:55:05
- Reporting Period:
- 2021-08-06
- Accepted Time:
- 2021-08-10 17:55:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1585160 | E Robert Landry | 777 Old Saw Mill River Road Tarrytown NY 10591 | Evp Finance Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-08-06 | 2,000 | $381.92 | 27,903 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-06 | 1,636 | $607.51 | 26,267 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2021-08-09 | 1 | $610.85 | 26,266 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-09 | 36 | $612.97 | 26,230 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-09 | 1 | $613.79 | 26,229 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-09 | 66 | $614.70 | 26,163 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-09 | 40 | $615.42 | 26,123 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-09 | 36 | $617.83 | 26,087 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-09 | 58 | $618.44 | 26,029 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-09 | 36 | $619.70 | 25,993 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-09 | 54 | $621.19 | 25,939 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-09 | 36 | $623.54 | 25,903 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-08-09 | 3,000 | $381.92 | 28,903 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-08-09 | 2,463 | $617.68 | 26,440 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2021-08-10 | 433 | $611.00 | 26,007 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-10 | 50 | $612.31 | 25,957 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-10 | 1 | $614.09 | 25,956 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-10 | 1 | $615.73 | 25,955 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-10 | 45 | $618.89 | 25,910 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-08-10 | 7 | $619.19 | 25,903 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-08-06 | 2,000 | $0.00 | 2,000 | $381.92 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-08-09 | 3,000 | $0.00 | 3,000 | $381.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 22,565 | 2026-12-16 | No | 4 | M | Direct | |
| 19,565 | 2026-12-16 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 229 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 36 shares of Company stock on August 9, 2021 at prices ranging from $612.97 to $612.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.
- Represents volume-weighted average price of sales of 66 shares of Company stock on August 9, 2021 at prices ranging from $614.34 to $614.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.
- Represents volume-weighted average price of sales of 40 shares of Company stock on August 9, 2021 at prices ranging from $615.35 to $615.51. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.
- Represents volume-weighted average price of sales of 36 shares of Company stock on August 9, 2021 at prices ranging from $617.73 to $617.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.
- Represents volume-weighted average price of sales of 58 shares of Company stock on August 9, 2021 at prices ranging from $618.14 to $618.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.
- Represents volume-weighted average price of sales of 36 shares of Company stock on August 9, 2021 at prices ranging from $619.48 to $619.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.
- Represents volume-weighted average price of sales of 54 shares of Company stock on August 9, 2021 at prices ranging from $621.02 to $621.40. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.
- Represents volume-weighted average price of sales of 36 shares of Company stock on August 9, 2021 at prices ranging from $623.40 to $623.69. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 9, 2021 at each separate price.
- Represents volume-weighted average price of sales of 45 shares of Company stock on August 10, 2021 at prices ranging from $618.13 to $618.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
- Represents volume-weighted average price of sales of 7 shares of Company stock on August 10, 2021 at prices ranging from $619.16 to $619.24. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.
- The stock option award vests in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
